| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.9 |
| mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.9 |
| mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |